# Frank Rimalovski

> Frank Rimalovski is a seed investor at NYU Innovation Venture Fund backing Software. See 10 investments, check sizes, portfolio and contact details. Updated…

- Type: Angel Investor
- Fund: [NYU Innovation Venture Fund](https://shizune.co/investors/profile/nyu-innovation-venture-fund)
- Location: New York, United States
- Total investments: 10
- Last investment: Dec 2014
- Lead investor: 10%
- Last updated: Oct 2026
- LinkedIn: http://www.linkedin.com/in/rimalovski
- X (Twitter): http://twitter.com/rimalovski
- Facebook: http://www.facebook.com/rimalovski

Frank Rimalovski is a venture capitalist with 18 years of early-stage investment and technology commercialization experience. Frank is managing director of the NYU Innovation Venture Fund, a seed-stage venture capital fund created in 2010 to invest in startups built upon technologies and intellectual property created by NYU students, facultyand researchers. Before joining NYU, he was a founding partner of New Venture Partners, the leading global venture capital firm dedicated to funding technology spinouts based on corporate innovations. At New Venture Partners, he led the successful investment in and spinout of multiple new ventures from Lucent/Bell Labs, British Telecom, IBM and IDEO, among others. New Ventures Partners manages over $800 million in investment capital, and as a team has completed in excess of 60 spinout transactions. Frank joined New Venture Partners from Lucent, where he was a director and entrepreneur-in-residence within Lucent New Ventures Group. For six years, he held various positions in marketing, business development and product management in Silicon Valley at Sun Microsystems, Apple and NeXT.Earlier in his career, he was an investment banker in the mergers and acquisitions groups of Bear Stearns and Rodman & Renshaw.Frank holds a BA in Economics from Tufts University and a MBA from Duke University Fuqua School of Business.

## Contacts

5 contacts available for Frank Rimalovski: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/frank-rimalovski?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 3 | 30% |
| Health Care | 3 | 30% |
| Biotechnology | 3 | 30% |
| Medical | 2 | 20% |
| Analytics | 2 | 20% |

31 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 6 | 60% |
| Series A | 2 | 20% |
| Funding Round | 1 | 10% |
| Venture - Series Unknown | 1 | 10% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 9 | 90% |
| United Kingdom | 1 | 10% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Framed Data | Framed Data takes data from businesses and turns it into actionable insights and decisions. They train, optimize, and store productionized models in their cloud and provide predictions through an API, eliminating infrastructure overhead. They provide dashboards and scenario analysis tools that tell you which company levers are driving metrics youcare about. | $2M | Seed | Dec 11, 2014 | http://www.framed.io |
| Keen Home | Keen Home develops proactive hardware and software products to protect and enhance your home's core systems. Keen Home’s products provide homeowners with increased comfort, improved efficiency, and a better maintained home. The company’s first product, the Smart Vent, seamlessly controls a home’s heating/cooling airflow on a room-by-roomlevel, resulting in improved comfort and efficiency. The Smart Vent launched in Lowe’s Home Centers in November 2015 and began shipping direct to customers in January 2016.Keen Home’s software platform will serve as the world’s first proactive home health dashboard while offering partners data for lead generation, actuarial insight for risk pricing, and control for peak load management.Keen Home was founded by Ryan Fant, Nayeem Hussain, and Will Mcleod in 2013 and is based in New York City. | $1.5M | Seed | Oct 29, 2014 | http://www.keenhome.io |
| Orca Pharmaceuticals | Orca Pharmaceuticals is a new biotechnology startup focusing on treating autoimmune diseases.Funding is from BioMotiv, a Cleveland, Ohio based therapeutics accelerator affiliated with The Harrington Project, and the New York University Innovation Venture Fund. The company, located in Oxford UK, is based on technology developed by inventors fromNew York University (NYU) in collaboration with the founders in the United Kingdom. | $1.3M | Venture - Series Unknown | Apr 28, 2014 | http://orcapharmaceuticals.com |
| BioDigital | BioDigital was founded on the premise that 3D technology could transform the way we understand health and medicine. The founders had witnessed its impact on gaming and Hollywood, and were determined to apply state-of-the-art 3D to healthcare as well. Together they opened BioDigital Systems – a biomedical visualization company – in New York City,and over the years, they have helped make biomedical information more accessible for a diverse list of clients, including hospitals, biotech and medical device companies, pharmaceuticals, non-profit organizations, and academic institutions.The reactions to BioDigital's 3D storytelling – from patients, physicians, healthcare providers, and educators - were so positive that in 2010, BioDigital decided to expand their technology to empower anyone with Internet access to learn about the human body - in a way that resembles life itself. A year later, the BioDigital Human was born. This interactive, medically accurate virtual body enables users to study anatomy, disease, and treatments. The platform is constantly evolving, as our team of software engineers, 3D animators, physicians, and scientists – all with specialized biology training – continue to add both content and features. | $4M | Series A | Sep 24, 2013 | https://www.biodigital.com/ |
| Vengo | Vengo is a software and media company that engages consumers and collects data by combining interactive digital media with point-of-purchase. Selected from 270 companies as "NYC Next Idea 2012," Vengo's next-generation vending machines enable brands such as Trident, Snapple, Dentyne, and Sour Patch Kids to re-engage consumers whilegenerating attractive unit economics (expect six-month payback on new units). Vengo already has established partnerships with Mondelez (one of the largest snack food companies), Snapple, Verizon, CC Vending (second-largest NYC vending machine provider), and Creative Mobile Technologies (NYC taxis). Vengo was founded in 2012 and headquartered in Long Island City, New York. | $1M | Seed | Feb 19, 2013 | https://vengolabs.com/ |
| numberFire | numberFire is an analytics framework that uses mathematical modeling and algorithmic analysis to understand, analyze, and predict sports performance. | $750K | Seed | Jan 05, 2012 | http://numberfire.com |
| Tagasauris | Tagasauris is the developer of a patent-pending human-assisted computing platform designed to “teach” computers the content of a picture or video and how that content relates to the rest of the web. This technology quickly and cost-effectively turns ordinary (“dumb”) visual content into rich searchable media at web-scale and is already being usedby corporate customers including Disney, AOL, and ABC. Clients benefit from improved engagement, traffic, and discoverability (e.g. Tagasauris increased website traffic for one client 5,000%+ after tagging 1.8M photos in one early use case). The company employs experts in the fields of linked data, dynamic semantic publishing, and human-assisted computing and is championed by one of the original members of the Watson team at IBM. Tagasauris was incorporated in 2010 and is headquartered in New York, United States. |  | Seed | Dec 07, 2011 | http://tagasauris.com |
| ShopWell | ShopWell is a personalized nutrition app that recommends foods to people based on their dietary needs and helps them build healthy grocery lists. It's like having a personal dietitian in the palm of your hands. At home or in the store, simply scan a food’s barcode to get nutrition info and find out if the food is right for you. ShopWellalleviates all the confusion of grocery shopping and even helps you discover new foods you’ll love. ShopWell is a Community Partner of the USDA and certified by Registered Dietitians. It’s free and easy to use. ShopWell Helps You:Achieve Health Goals - Such as weight management, lower cholesterol, & manage diabetesEat More of the Things You Want - Such as calcium, fiber, & whole grainsAvoid Things You Don’t Want - Such as sugar, trans fat, & sodiumStay Clear of Allergens & Intolerance - Such as gluten, peanuts, & lactoseBuild healthy grocery lists | $1.1M |  | Sep 14, 2010 | http://www.shopwell.com |
| Fondu | Fondu (formerly SpotOn) was a community for sharing bite-sized reviews about places to eat and drink. Users wrote a short review of places they visited and gave it a rating of 1-4 "petals" that got pushed to their followers in the community. After launching SpotOn as an NYC only beta at TechCrunch Disrupt NYC in May, the team spent a lotof time refining the recommendation engine and testing with users. Based on extensive user feedback, the team decided to evolve their product into a social network for bite-sized reviews and renamed the company to Fondu. Fondu was acquired by [Airbnb] (http://www.businessinsider.com/airbnb-buys-fondu-2012-10) in 2012 | $575K | Seed |  | http://fondu.com |
| TB Biosciences | TB Biosciences, Inc. is an early stage development medical diagnostics company founded in June 2013 to develop a rapid point-of-care tuberculosis test that meets performance standards around the world. The goal of TB Biosciences is to commercialize a simple to operate and use tuberculosis test that replaces the 125 year old sputum smear test. TheCompany is using an array of patented peptides developed and exclusively licensed from the NYU School of Medicine. | $1.5M | Series A |  | http://tbbiosciences.com |

10 of 10 investments shown.

## Co-investors
- [R/GA Ventures](https://shizune.co/investors/profile/r-ga-ventures) — VC Fund, 2 deals together
- [American Family Ventures](https://shizune.co/investors/profile/american-family-ventures) — VC Fund, 1 deal together
- [BioMotiv](https://shizune.co/investors/profile/biomotiv) — VC Fund, 1 deal together
- Blazer Ventures — VC Fund, 1 deal together
- [Brand Foundry Ventures](https://shizune.co/investors/profile/brand-foundry-ventures) — VC Fund, 1 deal together
- [Techstars Ventures](https://shizune.co/investors/profile/bullet-time-ventures) — VC Fund, 1 deal together

## About NYU Innovation Venture Fund

VC Fund · New York, United States

NYU's seed-stage venture capital fund invests exclusively in startups founded by, and/or commercializing technologies and intellectual property developed by current NYU students, faculty, and researchers. The Fund will provide needed capital, contacts with the entrepreneurial and venture communities, and just as important, practicall management and marketing expertise to transform NYU ideas and inventions into successful, growing companies. The Fund makes approximately three to four investments per year in partnership with other angel investors and seed/venture capital funds. The Fund will recycle investment returns from the successful sale of portfolio companies back into the University to finance further research and future ventures.

4 contacts available at NYU Innovation Venture Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Dee Dao | Investment Associate | https://shizune.co/investors/profile/dee-dao |
| Emily Baum | Venture Associate | https://shizune.co/investors/profile/emily-baum |
| Frank Rimalovski | Managing Director | https://shizune.co/investors/profile/frank-rimalovski |
| Sergei Revzin | Venture Associate | https://shizune.co/investors/profile/sergei-revzin |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

## FAQ

### What does Frank Rimalovski invest in?

Frank Rimalovski invests primarily in Software, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Frank Rimalovski?

Public channels for Frank Rimalovski include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Frank Rimalovski last invest?

The most recent investment recorded for Frank Rimalovski closed in Dec 2014. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co